PI-LAB-2024-056

Retatrutide, Independent Lab Report

Retatrutide 5mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 98% met the stated ≥98% claim. Content measured 98.3% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
98.0%

Label claimed ≥98%

Content accuracy
98.4%

4.92mg measured against 5mg claimed

Test recency
Older result

Published 22 months ago

Specimen PI-LAB-2024-056 Tested by Meridian Bioanalytical 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 98% Meets claim
Identity (MS) Retatrutide Confirmed Matches label
Content 5 mg 4.92 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Meridian Bioanalytical. See our full testing methodology.

Lot / batch
C4181-24
Purchased
Analysed
Published
Laboratory
Meridian Bioanalytical
Test type
Content verification

Original laboratory report: PI-LAB-2024-056-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, Retatrutide

Retatrutide Vector Peptide Supply
Purity 97.6% Verified
Retatrutide NextGen Peptides
Purity 99.7% Verified
Retatrutide Cardinal Metabolic Clinic
Purity 93.7% Verified